David Goldstein
Co-founder, President and Executive Chair · Setara Biosciences
Biotechnology · Series A
Latest raise
$90M
Date raised
October 30, 2026
Round
Series A
About David Goldstein
a clinical-stage rare disease biotech formed by Actio Biosciences alums
- Who is David Goldstein?
- David Goldstein is listed as Co-founder, President and Executive Chair of Setara Biosciences, a biotechnology company.
- How much did Setara Biosciences raise?
- Setara Biosciences raised $90M in a Series A round on October 30, 2026 (3 days ago).
Get newly funded founders every week
A free weekly list of startups that just raised.